Connelly T J, Coronado R
Department of Anesthesiology, University of Wisconsin, Madison 53792.
Anesthesiology. 1994 Aug;81(2):459-69. doi: 10.1097/00000542-199408000-00025.
Depression of myocardial contractility associated with the volatile anesthetics is well established clinically and experimentally. The molecular mechanisms underlying this effect, however, have not been completely characterized. Whereas the Ca2+ release channel of cardiac sarcoplasmic reticulum (SR) has been implicated as a potential target contributing to anesthetic-induced myocardial depression, the effect of the volatile anesthetics on this protein have not been characterized at the isolated, single-channel level. The authors sought to identify changes in channel gating and conductance resulting from exposure to halothane, enflurane, and isoflurane that would contribute to the associated negative inotropy, as well as to explain the observation that isoflurane causes less contractile depression than either halothane or enflurane.
Vesicles enriched in SR were prepared from porcine left ventricular tissue. Fusion of these vesicles with artificial lipid bilayers under the experimental conditions provided single-channel recordings of the SR Ca2+ release channel. The gating properties and the conductance of these channels were determined in the presence and absence of clinical concentrations of halothane, enflurane, and isoflurane.
Halothane (1.2 vol%) and enflurane (1.6 vol%) activated the Ca2+ release channel by increasing the open probability (fraction of time that the channel is open) without altering the channel conductance. These agents altered channel gating by increasing the duration of open events, rather than the number of open events. Isoflurane (1.4 vol%) had no effect on channel gating or conductance. Halothane caused dose-dependent channel activation (0.2-1.5 vol%), and channel activation was found to be reversible upon washout of halothane from the solutions bathing the lipid bilayer.
Halothane and enflurane gate the Ca2+ release channel into the open state without altering the channel conductance. An increase in the duration of open events results from halothane and enflurane, but does not occur in the presence of isoflurane. Activation of the SR Ca2+ release channel would lead to loss of SR stores of Ca2+ into the cytoplasm, which is rapidly mobilized to the extracellular space. A net depletion of Ca2+ available for excitation-contraction coupling would result. The observation that isoflurane does not alter gating of this channel contributes to the understanding of the molecular mechanisms by which isoflurane depresses myocardial contractility less than halothane and enflurane.
挥发性麻醉药所致心肌收缩力抑制在临床和实验中均已得到充分证实。然而,这种效应背后的分子机制尚未完全明确。尽管心脏肌浆网(SR)的Ca2+释放通道被认为是麻醉药所致心肌抑制的一个潜在靶点,但挥发性麻醉药对该蛋白的作用在分离的单通道水平上尚未得到明确。作者试图确定暴露于氟烷、恩氟烷和异氟烷后通道门控和电导的变化,这些变化可能导致相关的负性肌力作用,并解释异氟烷所致收缩抑制比氟烷或恩氟烷轻的现象。
从猪左心室组织制备富含SR的囊泡。在实验条件下,这些囊泡与人工脂质双层融合,提供SR Ca2+释放通道的单通道记录。在有和没有临床浓度的氟烷、恩氟烷和异氟烷存在的情况下,测定这些通道的门控特性和电导。
氟烷(1.2体积%)和恩氟烷(1.6体积%)通过增加开放概率(通道开放时间的比例)激活Ca2+释放通道,而不改变通道电导。这些药物通过增加开放事件的持续时间而非开放事件的数量来改变通道门控。异氟烷(1.4体积%)对通道门控或电导无影响。氟烷引起剂量依赖性通道激活(0.2 - 1.5体积%),并且发现从脂质双层浴液中洗去氟烷后通道激活是可逆的。
氟烷和恩氟烷使Ca2+释放通道进入开放状态而不改变通道电导。氟烷和恩氟烷导致开放事件持续时间增加,但在异氟烷存在时不发生。SR Ca2+释放通道的激活将导致SR中Ca2+储存释放到细胞质中,后者迅速转运到细胞外空间。可用于兴奋 - 收缩偶联的Ca2+将出现净消耗。异氟烷不改变该通道门控的观察结果有助于理解异氟烷比氟烷和恩氟烷对心肌收缩力抑制作用小的分子机制。